advances in management of her2-positive breast cancer
Published 2 years ago • 22 plays • Length 7:18Download video MP4
Download video MP3
Similar videos
-
9:02
novel therapies in the management of her2-positive breast cancer
-
3:52
immunotherapy in the neoadjuvant management of her2-positive breast cancer
-
30:27
advances in her2-positive and her2-low breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
6:39
expert report on advances in the management of her2-negative and her2-low advanced breast cancer
-
4:36
kimberly blackwell on advances in the management of her2 patients.mp4
-
1:05:11
ask the expert: early-stage her2-positive breast cancer with adrienne waks, md
-
20:39
lump to breast cancer - alison | triple positive breast cancer | the patient story
-
5:58
metastatic breast cancer with bone-only metastases
-
4:45
advances and considerations in the treatment and management of hr , her2-, advanced breast cancer
-
1:43
phase i study of anti-her2 car-engineered monocytes in her2-overexpressing solid tumors
-
1:55
advances in treatments for her2-positive metastatic breast cancer
-
2:43
sequencing treatment options in her2 positive breast cancer: 2023 best of breast conference
-
4:30
kimberly blackwell on advances in the management of her2 patients
-
1:48
dr. verma on advances in the treatment of metastatic her2-positive breast cancer
-
22:50
neoadjuvant therapy for her2-positive breast cancer - dr. scott christensen
-
4:01
management of her2 positive metastatic breast cancer treatment algorithm
-
53:19
her2 positive breast cancer: what's new in treatment and research at mbc patient forum 2019
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases
-
31:21
novel therapeutics for breast cancer: her2 and triple negative disease; new pathways, targets
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute